Agilon Health, Inc. (AGL), Amphastar Pharmaceuticals, Inc. (AMPH), and Crane Company (CR) have been added to the Zacks Rank #24 (Strong Sell) List as of today. Over the past 60 days, the Zacks Consensus Estimate for Agilon’s current year earnings has been revised downward by 59%. Amphastar’s earnings estimate has decreased by 3%, while Crane’s has been adjusted down by 5.7%.
These revisions indicate significant downward pressure on anticipated earnings for these companies, reflecting broader market or operational concerns affecting their financial outlooks.
